Pathological GamblingNCT01528982
Susceptibility to Pathological Gambling
A study testing Mindfulness and Cognition in people with Pathological Gambling, run by University of Chicago at 1 site in United States.
Trial summary
The goal of this study is to assess the risk factors for the development of pathological gambling. Read more about this study
- Who is it for?
- Ages 18 to 29 yearsHealthy volunteers can take part
- Conditions the study is for
- Pathological Gambling
- What is being tested?
- Mindfulness and Cognition
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 588 participants
- Where
- 1 siteUnited States
- Study dates
- Nov 2008to Jun 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 29 years
- All sexes
- Healthy volunteers accepted
- Adult
Who may be able to join
- Ability to understand the procedures and provide written consent
- Gambled at least 5 times in the past year
- Between the ages of 18 and 29 at intake
Who cannot join
- Inability to understand the procedures and provide written consent
Trial locations and contacts
1 site in 1 country.
About this study
The goal of this study is to assess the risk factors for the development of pathological gambling.
Read the detailed description
This study will track up to 600 young adults (ages 18 to 29) for a two-year period, collecting variables such as gambling behavior, drug and alcohol use, psychiatry and medical history, family history, impulsivity, quality of life, self-esteem, and cognition. For some individuals who meet criteria as being impulsive, they will be randomized to receive an intervention to help reduce their impulsivity.
- Conditions
- Pathological Gambling
- Being tested
- Mindfulness, Cognition
- Medical subject headings
- Gambling
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
MindfulnessBehavioural
Also called Training
Subjects receive mindfulness training
CognitionBehavioural
Also called Training
Subject receive cognitive training
| Study group | Role | What they receive |
|---|---|---|
| Control | No intervention | Psychoeducation |
| Mindfulness | Active comparator | Mindfulness activity and psychoeducation Receives: Behavioral: Mindfulness |
| Cognition | Active comparator | Cognitive training and psychoeducation Receives: Behavioral: Cognition |
What is being measured
The primary outcome is the main question the study is designed to answer.
Structured Clinical Interview for Pathological Gambling (SCI-PG)
The SCI-PG is a validated and reliable scale assessing the presence of DSM-IV criteria for pathological gambling. The number of criteria met for PG is added for a total score and those meeting 5 or more criteria have DSM-IV pathological gambling.
Subjects are expected to be followed for the duration of the 3 year study.
Diagnostic criteria for pathological gambling every 3 months for the length of the study
Measured: Up to 3 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Feb 2012 (estimated)
- Study startNov 2008
- Primary completionJun 2024
- Study completionJun 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pathological GamblingStudies of the same condition, open and under way.
- More trials run by University of ChicagoThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 588 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Chicago
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Jon E Grant, JD, MD, MPH, Principal investigator, University of Chicago, Department of Psychiatry
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01528982
- Sponsor's protocol ID
- IRB12-1237
- Status last verified
- Jul 2024
- First submitted
- 30 Aug 2011
- Last updated
- 1 Aug 2024
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 1 Aug 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Susceptibility to Pathological Gambling
- ClinicalTrials.gov ID
- NCT01528982
- Acronym / sponsor ID
- IRB12-1237
- Conditions
- Pathological Gambling
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 588 participants (actual)
- Lead sponsor
- University of ChicagoUniversity, hospital or other
- Study start
- Nov 2008
- Primary completion
- Jun 2024 (actual)
- Study completion
- Jun 2024 (actual)
- First posted
- 8 Feb 2012 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this study is to assess the risk factors for the development of pathological gambling.
Detailed description
This study will track up to 600 young adults (ages 18 to 29) for a two-year period, collecting variables such as gambling behavior, drug and alcohol use, psychiatry and medical history, family history, impulsivity, quality of life, self-esteem, and cognition. For some individuals who meet criteria as being impulsive, they will be randomized to receive an intervention to help reduce their impulsivity.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Control | No intervention | –Psychoeducation |
| Mindfulness | Active comparator | Behavioral: MindfulnessMindfulness activity and psychoeducation |
| Cognition | Active comparator | Behavioral: CognitionCognitive training and psychoeducation |
Who may qualify
- Ages
- 18 to 29 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (3 listed)
- Ability to understand the procedures and provide written consent
- Gambled at least 5 times in the past year
- Between the ages of 18 and 29 at intake
Key exclusion criteria (1 listed)
- Inability to understand the procedures and provide written consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| MindfulnessAlso: TrainingSubjects receive mindfulness training | Behavioural | Mindfulness |
| CognitionAlso: TrainingSubject receive cognitive training | Behavioural | Cognition |
Primary outcome
Structured Clinical Interview for Pathological Gambling (SCI-PG)
Time frame: Up to 3 years
The SCI-PG is a validated and reliable scale assessing the presence of DSM-IV criteria for pathological gambling. The number of criteria met for PG is added for a total score and those meeting 5 or more criteria have DSM-IV pathological gambling. Subjects are expected to be followed for the duration of the 3 year study. Diagnostic criteria for pathological gambling every 3 months for the length of the study
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 Aug 2024.
Related trials for Pathological Gambling
Not yet recruiting
Theory-based Intervention for Promoting Responsible Gambling Among College Students
Problem Gambling, Pathological Gambling
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jon E Grant, JD, MD, MPH principal investigator
University of Chicago, Department of Psychiatry
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Mindfulness and Cognition in people with Pathological Gambling, run by University of Chicago at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 1 Aug 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Structured Clinical Interview for Pathological Gambling (SCI-PG) (time frame: Up to 3 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Aug 2024; AzTrials last refreshed its copy on 29 Oct 2026.